Vimarsana
Biggest News Aggregation in the World

Page 33 - Multiple System Atrophy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Multiple System Atrophy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Multiple System Atrophy Today - Breaking & Trending Today

The Multiple System Atrophy Coalition Surpasses $3.5 Million in Total MSA Research Funding - Vimarsana News

The Multiple System Atrophy Coalition Surpasses $3.5 Million in Total MSA Research Funding

McLean, VA (PRWEB) December 14, 2022 -- The Multiple System Atrophy (MSA) Coalition, the leading nonprofit funder of global MSA research, announced that the

Source: prweb.com
Inhibikase Therapeutics Announces Dosing of First Subjects in its '501' Bioequivalence Study of IkT-001Pro - Vimarsana News

Inhibikase Therapeutics Announces Dosing of First Subjects in its '501' Bioequivalence Study of IkT-001Pro

/PRNewswire/ -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) ("Inhibikase" or "Company"), a clinical-stage pharmaceutical company developing protein kinase...

Investegate |IXICO plc Announcements | IXICO plc: Contract Win - Vimarsana News

Investegate |IXICO plc Announcements | IXICO plc: Contract Win

Investegate announcements from IXICO plc, Contract Win

Inhibikase Therapeutics Provides Update to FDA Clinical Hold of IkT-148009 Programs - Vimarsana News

Inhibikase Therapeutics Provides Update to FDA Clinical Hold of IkT-148009 Programs

BOSTON and ATLANTA, Dec. 7, 2022 /PRNewswire/ -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) ('Inhibikase' or the 'Company'), a clinical-stage pha...

Inhibikase Therapeutics Provides Update to FDA Clinical Hold of IkT-148009 Programs - Vimarsana News

Inhibikase Therapeutics Provides Update to FDA Clinical Hold of IkT-148009 Programs

/PRNewswire/ -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) ("Inhibikase" or the "Company"), a clinical-stage pharmaceutical company developing protein kinase...